(Q36007599)

11 August 2017

1 reference

title

Interaction of warfarin with drugs, natural substances, and foods (English)

1 reference

11 August 2017

1 reference

1

David J Greenblatt

1 reference

11 August 2017

2

Lisa L von Moltke

1 reference

11 August 2017

1 February 2005

1 reference

The Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

45

1 reference

11 August 2017

2

1 reference

11 August 2017

127-132

1 reference

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Clinical practice. Care of patients receiving long-term anticoagulant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Management of haemorrhagic complications associated with oral anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

CYP2C9 allelic variants: ethnic distribution and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Pharmacogenetics of warfarin elimination and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Warfarin dose adjustments based on CYP2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Clinically important drug interactions with anticoagulants. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Interactions of warfarin with drugs and food

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Rifampin and rifabutin drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Pharmacokinetic interactions with rifampicin : clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Binding of drugs to serum albumin (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Protein binding displacement interactions and their clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Protein binding drug displacement interactions fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

What is the true clinical significance of plasma protein binding displacement interactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Changes in plasma protein binding have little clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Subtherapeutic INR values associated with a switch to generic warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

The association of vitamin K status with warfarin sensitivity at the onset of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Vitamin K content of nuts and fruits in the US diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Silent infection of Giardia lamblia causing bleeding through vitamin K malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Levofloxacin and warfarin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Herb-drug interactions: review and assessment of report reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Pharmacokinetic interactions between herbal remedies and medicinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Review of abnormal laboratory test results and toxic effects due to use of herbal medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Potentiation of warfarin by dong quai

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Probable antagonism of warfarin by green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Inhibition of human cytochromes P450 by components of Ginkgo biloba

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Herbal medicines and perioperative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Effect of diet and nutrition on the expression of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

21 January 2018

Food-drug interactions

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Effects of food on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Dietary Effects on Drug Metabolism and Transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Possible interaction between warfarin and cranberry juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004271404

21 January 2018

Identifiers

DOI

10.1177/0091270004271404

1 reference

11 August 2017

1 reference

PubMed ID

15647404